iVeena
Developer of a novel proprietary drug candidate designed to treat ophthalmic diseases. The company's drug candidate offers a cure for post-surgery cataract inflammation, macular degeneration, diabetic...
Valuation
$0
Share Price
N/A
Total Raised
$8.9M
Last Round
N/A